🇺🇸 FDA
Patent

US 12201685

Methods of modulating immune responses with cationic lipid vaccine compositions

granted A61KA61K2039/55511A61K2039/55516

Quick answer

US patent 12201685 (Methods of modulating immune responses with cationic lipid vaccine compositions) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/55511, A61K2039/55516, A61K2039/55522, A61K2039/55555